Coaxial MICS with toric IOL is a safe and effective treatment for cataract patients

Article

Implantation of a toric IOL after microincision cataract surgery (MICS) is a safe and successful way to correct astigmatism in cataract patients.

Implantation of a toric IOL after microincision cataract surgery (MICS) is a safe and successful way to correct astigmatism in cataract patients, stated a study published in the Journal of Cataract and Refractive Surgery.

Professor Jorge L. Alió et al., Vissum-Instituto Oftalmológico de Alicante, Spain, conducted a prospective, nonrandomized study on 21 eyes of 12 patients who had moderate to high astigmatism and cataracts. MICS was performed on all patients, followed by the implantation of an Acri.Comfort 646 TLC toric IOL in the capsular bag.

The outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), residual refractive sphere, residual refractive and keratometric cylinders and IOL axis alignment. All were measured 3 months postoperatively and the Alpins method was used to measure vector analysis of astigmatism.

It was found that the UDVA was 20/40 or better in 16 eyes and CDVA was 20/30 or better in 18 eyes. The mean refractive cylinder reduced postoperatively from -4.46 D ± 2.23 D to -0.45 D to 0.63 D. The mean index of success was 0.11 ± 0.15, with 91% of astigmatism corrected. Mean IOL axis rotation was -1.75˚ ± 2.93˚and the rotation was 10˚ or lower in all eyes.

The combination of MICS and toric IOL implantation posed no risks or complications. It was considered as a safe and accurate way of eradicating moderate to high astigmatism in cataract patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.